Recent evidence provides support for involvement of the microbiota-gut-brain axis in Parkinson's disease (PD) pathogenesis. We propose that a pro-inflammatory intestinal milieu, due to intestinal hyper-permeability and/or microbial dysbiosis, initiates or exacerbates PD pathogenesis. One factor that can cause intestinal hyper-permeability and dysbiosis is chronic stress which has been shown to accelerate neuronal degeneration and motor deficits in Parkinsonism rodent models. We hypothesized that stress-induced intestinal barrier dysfunction and microbial dysbiosis lead to a pro-inflammatory milieu that exacerbates the PD phenotype in the low-dose oral rotenone PD mice model. To test this hypothesis, mice received unpredictable restraint stress (RS) for 12 weeks, and during the last six weeks mice also received a daily administration of low-dose rotenone (10 mg/kg/day) orally. The initial six weeks of RS caused significantly higher urinary cortisol, intestinal hyperpermeability, and decreased abundance of putative "anti-inflammatory" bacteria (Lactobacillus) compared to non-stressed mice. Rotenone alone (i.e., without RS) disrupted the colonic expression of the tight junction protein ZO-1, increased oxidative stress (N-tyrosine), increased myenteric plexus enteric glial cell GFAP expression and increased α-synuclein (α-syn) protein levels in the colon compared to controls. Restraint stress exacerbated these rotenone-induced changes. Specifically, RS potentiated rotenone-induced effects in the colon including: 1) intestinal hyper-permeability, 2) disruption of tight junction proteins (ZO-1, Occludin, Claudin1), 3) oxidative stress (N-tyrosine), 4) inflammation in glial cells (GFAP + enteric glia cells), 5) α-syn, 6) increased relative abundance of fecal Akkermansia (mucin-degrading Gram-negative bacteria), and 7) endotoxemia. In addition, RS promoted a number of rotenone-induced effects in the brain including: 1) reduced number of resting microglia and a higher number of dystrophic/phagocytic microglia as well as (FJ-C+) dying cells in the substantia nigra (SN), 2) increased lipopolysaccharide (LPS) reactivity in the SN, and 3) reduced dopamine (DA) and DA metabolites (DOPAC, HVA) in the striatum compared to control mice. Our findings support a model in which chronic stressinduced, gut-derived, pro-inflammatory milieu exacerbates the PD phenotype via a dysfunctional microbiota-gut-brain axis. (A. Keshavarzian).
Introduction
The etiology of Parkinson's disease (PD) is not clear but evidence strongly suggests that chronic neuroinflammation is a factor contributing to neurodegeneration (Bartels & Leenders, 2007; Block & Hong, 2005; Hirsch & Hunot, 2009; McGeer & McGeer, 2004; Norden et al., 2015; Sekiyama et al., 2012; Xanthos & Sandkuhler, 2014) . The underlying source of the neuroinflammation is unknown; but recent observational studies in PD https://doi.org/10. 1016/j.nbd.2018.12.012 Received 12 June 2018; Received in revised form 19 November 2018; Accepted 19 December 2018 patients and experimental studies provide compelling evidence for a gutderived, pro-inflammatory state as an important source for neuroinflammation and neurodegeneration in PD. (Abbott et al., 2001; Petrovitch et al., 2009; Clairembault et al., 2015; Devos et al., 2013; Forsyth et al., 2012; Scheperjans et al., 2015; Keshavarzian et al., 2015) For example, newly diagnosed PD patients exhibit intestinal hyperpermeability and endotoxemia, as well as gut microbiota dysbiosis (i.e., an abnormal intestinal microbiota composition and function) (Forsyth et al., 2012; Keshavarzian et al., 2015) . While this finding cannot distinguish between disease cause and effect, it does provide a strong rationale to investigate the hypothesis that gut-derived inflammation, due to intestinal hyper-permeability or dysbiosis, promotes neuroinflammation and neurodegenerative changes relevant to PD pathogenesis.
If the gut is promoting PD pathogenesis then factors that cause gut leakiness to endotoxins and/or dysbiosis should exacerbate PD-associated pathologies and the phenotype. One such environmental factor is chronic stress. Indeed, several animal and human studies have shown that chronic stress promotes both intestinal hyperpermeability and dysbiosis (Zheng et al., 2013; Zheng et al., 2017; Soderholm & Perdue, 2001; Bailey & Coe, 1999; Gareau et al., 2008; Mackos et al., 2016) . Compelling data suggest that patients with PD experience a high level of stress (Charcot, n.d.; Gowers, 1988) with PD patients having higher cortisol levels than healthy controls (Charlett et al., 1998) . Despite these data, it is not clear if stress-induced intestinal hyper-permeability or dysbiosis is important in the pathogenesis of PD or just a consequence of PD. However, previous studies in rodents show that stress is sufficient to cause microglial activation, neuroinflammation, and loss of dopaminergic neurons in the SN (Sugama et al., 2016; Hemmerle et al., 2014; de Pablos et al., 2014) . Therefore, it is possible that stress-induced effects on the gut (intestinal hyperpermeability/dysbiosis) may promote neuroinflammation and neurodegeneration.
Accordingly, we hypothesized that chronic stress causes disruption of the intestinal barrier and intestinal dysbiosis resulting in exacerbation of PD pathology. To this end, we used unpredictable chronic restraint (12 weeks) to induce stress in combination with low-dose oral rotenone (last 6 weeks) to explore dysfunctional gut-brain axis in proposed PD mice model (Pan-Montojo & Funk, 2010) .
Results

Measures of stress parameters support the effectiveness of the chronic restraint stress (RS) protocol
The experimental protocol is outlined in Fig. 1A . Four different parameters were recorded and analyzed to confirm effectiveness of RS protocol including: body weight, food consumption, fecal output, and urinary cortisol. 1) Body Weight (Fig. 1B) . Analysis of body weight data revealed a significant effect of stress on body weight (rmANOVA: (group) F[5, 79] = 12.19, P = .002; (time) F (7,168) = 12.18, P < .0001; (interaction) F (7, 168) = 22.22, P < .0001). Post-hoc analysis showed significantly lower body weight in the RS groups compared to controls at week 3 (P < .01), week 5 (P < .001), week 7 (P < .001), week 9 (P < .001), week 11 (P < .01), and week 13 (P < .001). Starting at week 9, body weight loss was noted in controls which may be a consequence of stress associated with the daily oral gavage (vehicle/rotenone) procedure. 2) Food Intake (Fig. 1C ). There were no significant differences in food intake between the control and RS groups (rmANOVA: F[5, 79] = 2.325, P = .14) nor a group and time interaction (P > .05); however there was a significant effect of time on food intake (F (4,96) = 148.9, P < .0001). 3) Fecal Output (Fig. 1D) . Fecal output during two-hours RS was significantly higher in the RS group compared to controls (rmANOVA: (groups) F[5, 79] = 147.3, P < .0001; (time) F (13, 312) = 10.82, P < .0001; (interaction) F (13, 312) = 5.443, P < .0001). Post-hoc analysis showed significantly higher fecal output in the RS group from week 3 through week 15 (P < .001). 4) Urinary Cortisol (Fig. 1E ). Baseline urinary cortisol levels were not significantly different (data not shown). Six weeks of RS significantly increased urinary cortisol (unpaired two-tailed t-test: t [22] = 2.49, P = .03). Taken together, these data confirm effectiveness of the unpredictable chronic RS protocol.
Restraint stress promoted rotenone-induced intestinal hyperpermeability, endotoxemia and tight junction barrier loss
Six weeks of RS significantly increased urinary excretion of sucralose/lactulose (unpaired two-tailed t-test: t[57] = 3.38, P = .002) compared to controls indicating intestinal hyperpermeability ( Fig. 2A) . In contrast, there were no significant changes in urinary excretion of sucrose (t[57] = 0.58, P = .570) or mannitol (t[57] = 0.13, P = .901) ( Fig. S1 :A, C-markers of small bowel permeability). Together these data suggest the site of disruption of intestinal barrier function is primarily colon . At week 15, there was still a significant effect of stress on the urinary sucralose/lactulose ratio ( Fig. 2B) (F[5, 28] = 11.91, P < .00) but no significant effect of rotenone nor a rotenone and stress interaction. Post-hoc analysis showed significantly increased sucralose/lactulose ratio in the RS + rotenone mice compared to rotenone mice (P < .05). Urinary excretion of sucrose or mannitol showed no significant differences between groups ( Fig. S1 : B, D).
Plasma LPS ( Fig. 2C ) and plasma lipopolysaccharide binding protein (LBP) (Fig. 2D) were measured at the time of sacrifice (week 15). Analysis revealed plasma LPS levels were significantly impacted by stress (F[5, 28] = 4.33, P < .05) but there was not a significant effect of rotenone nor rotenone and stress interaction. Post-hoc analysis showed significantly increased plasma LPS levels in RS + rotenone compared to rotenone treatment alone (P < .05). Plasma LBP levels were significantly impacted by rotenone (F[5, 28] = 7.14, P = .01) but no significant effects of stress nor was a rotenone and stress interaction observed (Fig. 2D ). Post-hoc analysis showed significantly higher LBP levels in RS + rotenone mice compared to RS alone (P < .05). Together these data suggest that stress exacerbated colonic hyperpermeability and endotoxemia.
Immunofluorescence staining for the tight junction proteins zonula occludens-1 (ZO-1), occludin, and claudin-1 showed evidence of intestinal barrier dysfunction ( Fig. 2E) . ZO-1. Visualization showed continuous, robust expression of ZO-1 (i.e., normal lattice structure distribution) at the epithelial lining of the control group while the rotenone group showed disrupted, non-continuous structure of ZO-1 ( Fig. 2E ). By comparison, RS resulted in complete disappearance of ZO-1 expression at the epithelial lining irrespective of rotenone exposure ( Fig. 2E ). Semi-quantitative analysis of the staining using an integrity scoring scale (0 = no staining -3 = continuous normal expression) showed significant difference due to stress (F[5, 28] = 12.57, P < .00; Fig. 2F ) but no significant effect of rotenone nor a rotenone and stress interaction. Post-hoc analysis showed a significantly lower integrity score in RS compared to controls (P < .00). Occludin. Microscopic analysis showed intact occludin staining in the epithelial lining of both control and rotenone-treated mice ( Fig. 2E ). In contrast, RS reduced the expression of occludin irrespective of rotenone treatment ( Fig. 2E ). Integrity scoring data for occludin expression showed significant effect of stress (F[5, 28] = 39.38, P < .00) but no significant effect of rotenone nor a rotenone by stress interaction (Fig. 2G ). Post-hoc analysis showed a significant difference between colonic occludin expression in RS and control mice (P < .00), RS + rotenone compared to rotenonetreated mice (P < .00). Claudin 1. Microscopic visualization showed robust expression of claudin-1 located in the colonic epithelial lining of the control group and this expression was significantly impacted by both stress (F[5, 28] = 5.71, P = .03) and rotenone (F[5, 28] = 4.56, P = .04) but an interaction was not observed (Fig. 2H ). Post-hoc analysis showed significantly lower expression of claudin-1 in RS + rotenone compared to rotenone (P < .05). These data indicate that stress and rotenone treatment affected different tight junction profiles with the RS + rotenone group showing the most prominent effects and this could explain why RS + rotenone showed a significant increase in the sucralose/lactulose ratio and markers of endotoxemia compared to RS and rotenone alone.
We also performed WB analysis on the levels of claudin1 and Occludin in tissue homogenates (n = 4/5) from the colon. There were no significant differences in the protein levels of these tight junctional proteins between groups (Fig. S1 E, F). It should be noted that several studies demonstrated that topography of the tight junction proteins is more critical than their protein levels for the regulation of the intestinal permeability. Indeed, abnormal redistribution of these tight junction proteins, detected by histology or immunofluorescence microscopy, is associated with abnormal intestinal permeability without any changes in their overall protein expressions (in whole GI wall or tissue lysate) in both rodents and human (Shen et al., 2011; Furuse et al., 1994; Rao et al., 2002; Bruewer et al., 2003; Bruewer et al., 2005; Seth et al., 2008; Suzuki & Hara, 2009 ).
Restraint stress lowered putative "anti-inflammatory" fecal microbiota and rotenone increased the relative abundance of putative "proinflammatory" fecal microbiota
We assessed mouse fecal microbiota structure at baseline, week 9 (after 6 weeks of stress), and at the time of sacrifice (week 15) ( Fig. 1A) , employing alpha and beta diversity analyses.
Baseline
At baseline, very small but significant differences in fecal microbial community structure were observed between RS and control group were subjected to unpredictable RS (2 h, 5 days/week) from week 3 to week 15 (time of sacrifice). Intestinal permeability was measured at baseline (week 1), after six weeks of RS (week 9), followed by six weeks of RS ± rotenone treatment (week 15). Graphs in panels represent (B) Body weight (rmANOVA showed significant effect of (group) F (1 , 24) = 12.19, P = .002; (time) F (7,168) = 12.18, P < .0001; (interaction) F (7, 168) = 22.22, P < .0001), (C) 24 h food intake (rmANOVA: F (1 , 24) = 2.325, P = .14), (D) fecal output data during 2 h of restraint stress (rmANOVA: (groups) F (1 , 24) = 147.3, P < .0001; (time) F (13, 312) = 10.82, P < .0001; (interaction) F (13, 312) = 5.443, P < .0001) and (E) urinary cortisol after six weeks of RS (week 9). RS group showed higher urinary cortisol compared to control (two-tailed, unpaired t-test: t[22] = 2.49, P = .03). Data are mean ± SEM for panels (B, C, and D) and mean + SEM for a panel (E). *P < .05, **P < .01, ***P < .001.
(caption on next page) H.B. Dodiya et al. Neurobiology of Disease xxx (xxxx) xxxx animals (Table 1 , Fig. 3A, Fig. S2A ). Specifically, the RS group had significantly different alpha diversity compared to the control group at multiple taxonomic levels (RS higher than control group: Phylum (Shannon index, Simpson index, evenness), Family (evenness); RS lower than the control group Family (richness)) ( Table 1) . Analysis of similarity (ANOSIM) revealed a significant difference in alpha diversity at baseline (Global R = 0.128; P = .028) (Table S1 ). Despite these difference in alpha diversity at baseline, there were no significant differences between individual taxa at the phylum, family, or genus taxonomic levels (FDR P < .05) between RS and control groups (Table  S2 ). (Voikar et al., 2005) weeks of stress At week 9, following six weeks of RS, there were no significant differences in alpha diversity between control and RS mice (Table 1) , similar to results observed by others (Galley et al., 2014) . Additionally, the overall microbial community were statistically indistinguishable between RS and controls groups, at the phylum, family, and genus taxonomic levels (ANOSIM Global R = 0.020, P = .267) (Table S1, Fig.  S2B ). However, examination of individual taxa between groups revealed that the relative abundance of one family and two genera were statistically different between control and RS mice after six weeks of stress (Table 2) . Specifically, the relative abundance of family Lactobacillaceae and genus Lactobacillus were decreased (P < .05) in RS mice ( Fig. 3B ); whereas the relative abundance of bacteria in genus Lachnospiraceae;Unclassified was significantly increased by RS (FDR-P = .02) compared to control mice (Table 2) , similar to results obtained by other groups (Galley et al., 2014) . Using a predicative assessment of the microbial community functional potential (PICRUSt), we identified three metabolic pathways that were decreased by RS (Table S3 ). This could suggest that stress impacts host's metabolism, as evident by the RS mice in this study not gaining weight ( Fig. 1D ). We acknowledge that the PICRUSt analyses only infer microbiota function and our results must be confirmed by the metabolomics and metagenomics in the future studies. (Gowers, 1988) 
Six
Twelve
weeks of stress
At the time of sacrifice (week 15), significant group differences were observed in alpha diversity at the taxonomic level of phylum (Table 1) . At the taxonomic level of phylum, there was a significant effect of rotenone on the Shannon Index (F[5, 79] = 8.47, P = .01), the Simpson Index (F[5, 79] = 8.77, P = .01) and evenness (F[5, 79] = 7.92, P = .01), but no significant effects from stress nor a rotenone by stress interaction. Post-hoc analysis showed Shannon index (RS vs. RS + rotenone, rotenone vs. RS; P < .05), Simpson index (RS vs. RS + rotenone; P < .05) and evenness (RS vs. RS + rotenone, rotenone vs. RS; P < .05) ( Table 1 & Fig. S2D ). Additionally, there was a significant rotenone by stress interaction observed for evenness (F[5, 79] = 4.376, P = .047), at the family taxonomic level. Post-hoc comparison showed no significant differences. When analyzing the beta diversity between the mice groups at week 15, there were significant differences in the overall microbial community at all taxonomic levels between control and RS groups (ANOSIM genus: R = 0.393; P = .010), as well as between RS and RS + rotenone groups (ANOSIM genus: R = 0.288; P = .011) ( Table S1 ). Compared to control mice, the RS group had an increased relative abundance of family Unclassified Clostridiales (P = .03) ( Table 3 ). However, the decrease in relative abundance of genus Lactobacillus in RS mice compared to control mice at week 9, was not observed at week 15. This finding may be the consequence of stress in the control mice due to daily oral gavage of vehicle starting at week 9. Additionally, PICRUSt analysis inferred that RS mice had decreased functional pathway relative abundances in both flavonoid (anti-inflammatory molecules) and degradation of DTT toxins, compared to control mice (Table S3 ). This data suggest that stress increases the likelihood of susceptibility for environmental toxins, such as rotenone, due to the gut microbiota.
Rotenone ± RS-induced effects
Although no taxa were significantly different between rotenonetreated and control mice using stringent FDR-P criteria, a less stringent statistical approach did show that rotenone-treated mice had decreased relative abundance of phylum Actinobacteria (P = .04) compared to controls (Table 3 , Fig. S2C ). In contrast, the combination of RS + rotenone treatment resulted in significant changes in the intestinal microbiota (Table 3 ). These significant differences included: decreased relative abundance of phyla Firmicutes (FDR-P = .01) and Actinobacteria (FDR-P = .02) and an increased relative abundance of Verrucomicrobia (FDR-P = .04) in the RS + rotenone mice compared to RS alone. At the family taxonomic level, we observed significantly decreased relative abundance in Coriobacteriaceae (FDR-P = .03) and trends of decreased relative abundance of Unclassified Clostridiales (P = .04), as well as trends for increased relative abundance of Verrucomicrobiaceae (P = .03) and genus Akkermansia (P = .03) in the RS + rotenone compared to RS alone. PICRUSt inferred increased relative abundance in Lipopolysaccharide-biosynthesis, Lipopolysaccharide-protein, ubiquinone system + biosynthesis, and bacterial secretion pathways in the fecal microbiota of RS + rotenone compared to RS alone (Table S3 ). These putative "pro-inflammatory" pathways have been detected in human Parkinson's disease and multiple systems atrophy fecal microbiota studies Engen et al., 2017) .
Gram negative bacteria
To explore the possibility that endotoxemia resulted from an increase in LPS producing gram-negative bacteria, we specifically investigated the relative abundance of gram-negative bacterial genera Desulfovibrio, Bacteroides, and Akkermansia (Fig. 3C ). We only included detected gram-negative bacteria at genus taxonomy for this comparison. These taxa showed no significant differences at baseline nor after six weeks of stress. However, the relative abundance of Akkermansia was significantly impacted by rotenone-treatment (F[5, 79] = 9.78, P < .00) and stress (F[5, 79] = 5.18, P = .03), but no rotenone by Restraint stress (RS) promoted rotenone-induced intestinal permeability, endotoxemia, and tight junction barrier loss. Mice were subjected to an initial six weeks of unpredictable RS (2 h/day, 5 days/week) followed by six weeks of RS ± Rotenone treatment. Graph in panels represent (A) Percent excretion of sucralose/ lactulose after six weeks of RS subtracted from the baseline. RS group showed higher % excretion of sucralose/lactulose compared to control (two-tailed, unpaired ttest: t[57] = 3.14, P < .00), (B) Percent excretion of sucralose/lactulose after 12 weeks of RS ± rotenone subtracted from the baseline (Two-way ANOVA showed significant effect of stress (F (1,22) = 11.91, P < .00) and no significant effects of rotenone nor an interaction), (C) Plasma levels of LPS endotoxin (Two-way ANOVA showed significant effect of stress (F (1,22) = 4.33, P < .05) and no significant effect of rotenone nor an interaction), and (D) plasma levels of LBP (Two-way ANOVA showed significant effect of rotenone (F (1,22) = 7.14, P = .01) and no effect of stress nor an interaction). (E) Representative immunofluorescence images for the tight junction proteins ZO-1, occludin, and claudin 1 in the colon tissue. Arbitrary scale of 0-3 scores (0 = no expression -3 = continuous normal expression of the barrier) was used to score barrier integrity. Graphs in panels represent (F) Integrity scoring data for ZO-1 (Two-way ANOVA showed significant effect of stress (F (1,22) = 12.57, P < .00) and no effect of rotenone nor an interaction), (G) integrity scoring data for occludin (Two-way ANOVA showed significant effect of stress (F (1,22) = 39.38, P < .00) and no effect of rotenone nor an interaction), and (H) Integrity scoring data for claudin 1 (Two-way ANOVA showed significant effect of stress (F (1,22) = 5.71, P = .03) and rotenone (F (1,22) = 4.56, P = .04) but no significant stress and rotenone interaction). Data are mean + SEM; *P < .05, **P < .01, ***P < .001; n = 14 mice in panel (A) and n = 7 mice/group (except RS + rotenone group (n = 5)) for all other panels (B-H). RS = restraint stress, LPS = Lipopolysaccharides, LBP = LPS binding protein, ZO-1 = Zonula occludens-1. Scale bar in E represents 50 μm and applies to all panels in E.
(caption on next page) H.B. Dodiya et al. Neurobiology of Disease xxx (xxxx) xxxx stress interaction was observed. Post-hoc analysis showed significantly increased relative abundance of Akkermansia in RS + rotenone group compared to RS (P < .05). No significant differences were observed in the other examined gram-negative taxa.
2.3.6. Firmicutes/bacteroidetes ratio Next, we examined the Firmicutes/Bacteroidetes (F/B) ratio between groups. The most common bacteria in human microbiota are gram-positive Firmicutes and gram-negative Bacteroidetes (Eckburg et al., 2005) and several studies have analyzed the ratio of relative abundance of F/B as an important marker of the disruption of microbiota community structure and one of the microbiota parameter associated with gut health (Verdam et al., 2013; Mariat et al., 2009; Hodin et al., 2012) . We found no significant differences in F/B ratio at baseline or after 6 weeks of RS. At the time of sacrifice (week 15), stress showed a significant effect on the F/B ratio (F[5, 79] = 4.322, P = .048) ( Fig. 3D ), but no significant effect of rotenone nor interaction. Post-hoc analysis showed no significant differences between any groups.
This data again showed that stress significantly affected microbiota community structure.
Short chain fatty acids (SCFA)
We also evaluated the levels of SCFA in the fecal pellets of these mice at the time of sacrifice (week 15) ( Fig. 3E-G ). There was a significant effect of stress on the SCFA butyrate in the stool (F[5, 11] = 5.706, P = .026), but no significant effects of rotenone nor an interaction ( Fig. 3E ). Post-hoc analysis showed no significant differences between any other groups. Levels of the SCFA acetate ( Fig. 3F ) and the SCFA propionate ( Fig. 3G ) showed no significant changes. These data suggest that RS specifically decreased the SCFA butyrate level and this could contribute to stress-induced disruption of intestinal barrier and pro-inflammatory state because butyrate is critical in maintaining normal barrier function (Peng et al., 2009; Lewis et al., 2010; Ploger et al., 2012) and low butyrate is associated with pro-inflammatory state (Zhang et al., 2018) .
Stress and rotenone treatment cause oxidative stress and inflammation in colon
Gross colonic morphology was evaluated using hematoxylin and eosin (H&E) stained slides ( Fig. 4A ). Overall, rotenone and RS mice resulted in increased immune cells infiltration in the lamina propria while RS + Rotenone resulted in even higher immune cells infiltration in the lamina propria. We next evaluated oxidative stress and inflammation in the colonic lamina propria (LP) and myenteric plexuses (MP).
n-Tyrosine reactivity in lamina propria (LP)
These data were analyzed in two different ways: staining intensity (i.e., optical density (OD)) and the number of n-tyrosine positive cells in lamina propria (LP). Immunofluorescence staining for the oxidative stress marker n-tyrosine ( Fig. 4B ) showed higher intensity of n-tyrosine staining intensity throughout the lamina propria of the rotenonetreated mice; while RS group showed increased n-tyrosine+ cells in the lamina propria. OD analysis of n-tyrosine staining intensity revealed a significant rotenone by stress interaction (F[5, 48] = 6.25, P = .02, Fig. 4C ) but no main effects of stress nor rotenone (P > .05). Post-hoc comparison showed significantly higher n-tyrosine intensity in the lamina propria of rotenone-treated mice compared to controls (P < .05). In contrast, n-tyrosine+ cell count was significantly influenced by stress (F[5, 48] = 10.69, P < .00) but not by rotenone-treatment nor a stress by rotenone interaction (p > .05) ( Fig. 4D ). Post-hoc comparison showed significantly higher n-tyrosine+ cells in the lamina propria of RS compared to controls (P < .05).
Inflammation
Next we examined the impact of rotenone and/or stress on the levels of the pro-inflammatory cytokine IL-1β ( Fig. 4E ) and enteric glial cell activity (glial fibrillary acidic protein (GFAP) + cells; Fig. 4F , G, H) in colonic tissue. Cytokine levels in tissue homogenates. Levels of IL-1β were significantly increased by stress (F[5, 28] = 9.08, P = .01) but there were no effects of rotenone nor a rotenone by stress interaction (p > .05). Post-hoc analysis showed IL-1β levels were significantly increased by RS compared to control (P < .05). To further determine whether rotenone and stress results in colonic inflammatory state, we measured additional cytokines and chemokines in the colonic tissue homogenates using Raybiotech mouse cytokine array kit. Array membranes were probed with pooled (n = 3/4 per group) colon tissue homogenates (300 μg of total protein lysate). Immunoblotting protocol was followed as per manufacturer's suggestion and OD values were generated from densitometric analysis to detect the levels of 22 cytokines/chemokines. Overall, RS colonic homogenates showed higher cytokines/chemokines compared to all other groups ( Fig. S3 A, B) . Specifically, IL-9 (P = .038) and IFN-gamma (P = .033) levels showed statistically higher levels in RS group compared to control (stress: F[5, 53] = 15.24, P = .0175, stress by rotenone interaction: F[5, 53] = 17.92, P = .013 respectively) ( Fig. S3 B) .
GFAP+ enteric glia cells reactivity in lamina propria (LP) and myenteric plexuses (MP)
Immunofluorescence staining showed different pattern of GFAP+ enteric glia reactivity in the lamina propria and myenteric plexuses (MP) of the colon tissue. First, GFAP distribution was characterized in the lamina propria ( Fig. 4G ) as mucosal enteric glia cells/projections are known to play crucial roles in barrier integrity health and regulating immune responses in the mucosa (Bush et al., 1998; Neunlist et al., 2013; Ruhl et al., 2004; Savidge et al., 2007; Kabouridis et al., 2015) . OD analysis of GFAP positive enteric glia cells in the lamina propria showed a significant rotenone by stress interaction (F[5, 28] = 5.43, P = .03) ( Fig. 4G ) but no main effects of rotenone or stress alone were observed (P > .05). Post-hoc analysis showed significantly less GFAP intensity in the lamina propria of rotenone-treated mice compared to controls (P < .05) and RS-treated mice compared to controls (P < .05) ( Fig. 4E ). Second, we characterized GFAP expression in the myenteric plexuses ( Fig. 4H) . A higher enteric glial reactivity (GFAP+ cells) in the myenteric plexuses is a sign of enteric inflammation. OD analysis of GFAP expression in the myenteric plexuses showed significant effects of stress (F[5, 28] = 17.49, P < .00) and rotenone (F[5, 28] = 53.49, P < .00), but no interaction was observed (p > .05). Post-hoc comparison revealed significantly higher GFAP intensity in Fig. 3 . Restraint stress (RS) and rotenone showed distinct changes in fecal microbiota and Short Chain Fatty Acid (SCFA) levels. (A) Stacked histograms depicting 90% of the rarefied sequences of microbial taxa (relative abundance of total bacteria at family) between mice fecal groups: No changes at baseline; significant differences observed at both week 9 and 15 between groups. (B) The relative abundance of genus Lactobacillus, specifically at week 9, indicated a significant decrease in RS mice compared to control mice. (C) The relative abundance of (detectable gram-negative) genera Desulfovibrio, Bacteroides, and Akkermansia at all three timepoints. Two-Way ANOVA indicated Akkermansia was significantly impacted by rotenone (F (1,24) = 9.78, P < .00) and stress (F (1,24) = 5.18, P = .03). At week 15, post-hoc analysis showed significantly higher relative abundance of g_Akkermansia in RS + rotenone group compared to RS (p < .05). (D) Two-Way ANOVA indicated stress showed significant effect on the F/B ratio (F (1,24) = 4.322, P = .048) at week 15. Fecal SCFAs measurement using gas chromatography are shown in (E) Butyrate, (F) Acetate and (G) Propionate at week 15. (E) Two-Way ANOVA indicated significant effect of stress on butyrate levels in the feces (F (1,21) = 5.706, P = .0264). Data are mean + SEM; *p < .05, **p < .01, ***p < .001; n = 14/group for baseline (week 1) and post-6 weeks RS (week 9) while n = 7 mice/group (except RS + rotenone group (n = 5)) after RS ± rotenone treatment (week 15). RS = restraint stress.
Table 1
Alpha diversity at Phylum, Family and Genus taxonomic levels. # represents n = 14 mice,! represents n = 7 mice, UT-test = Unpaired t-test, ANOVA = One way ANOVA followed by Tukey post-hoc comparisons.
rotenone-treated mice compared to controls (P < .00), RS compared to controls (P < .05), RS + rotenone compared to RS (P < .00), and RS + rotenone compared to rotenone (P < .05).
Alpha-synuclein reactivity in myenteric plexuses (MP)
Next we evaluated the effects of stress and/or rotenone on PD-like pathology in the colonic myenteric plexuses (Fig. 4F, I) , specifically αsynuclein (α-syn). Rotenone-treated mice had higher α-syn level compared to controls. OD analysis showed significant effects of rotenone (F [5, 28] = 21.17, P < .00) but no effect of stress nor was there a stress by rotenone interaction (p > .05). Post-hoc analyses showed significantly higher α-syn in the myenteric plexuses of rotenone-treated mice compared to control mice (p < .01) and RS + rotenone treated mice compared to RS group (p < .05).
2.5. Restraint stress in combination with rotenone promotes neuroinflammation in the absence of rotenone in the brain
Rotenone level in the brain
It has been reported that low dose (10 mg/kg), orally administered rotenone does not reach to the brain (Pan-Montojo & Funk, 2010). To confirm this result, rotenone content was examined within the pooled brain regions of olfactory bulb, cortex, and rostral striatum via HPLC-MS in rotenone and RS + rotenone groups at the time of sacrifice (week 15). This analysis revealed that levels of rotenone in the brain were below the detectable range ( Fig. S4 ). Even though we found no detectable rotenone in the brain, it is still possible that rotenone effects in the brain is not from its impact on gut and is due to systemic absorption of the rotenone leading to immune activation resulting in neuro-inflammation. To exclude this possibility, we measured rotenone levels in the liver tissue and found no significant changes in total rotenone content of the liver samples (t[13] = 0.950, P = .364) (Table S4 ). Thus, the impact of stress on rotenone-induced brain dysfunction is not from increased systemic absorption of rotenone. This supports the role for disrupted gut-brain axis in our proposed Parkinsonism rodent model.
Iba ± microglia phenotype in SN
To characterize brain inflammation, we evaluated Iba1+ microglia cells. Microglial cells in the SN were analyzed based on their morphology (see Methods Section). Upon visual inspection, brain tissue from mice undergoing RS was characterized by microglia with a larger cell body with many processes that are thought to be activated microglia whereas brain tissue from rotenone-treated mice showed microglia with a large cell body with fewer processes indicative of dystrophic/phagocytic microglia (Fig. 5A ). Based on these morphological characteristics (Fig. 5B) , cell counts were estimated for microglia show optical density analysis of n-tyrosine reactivity (Two-way ANOVA showed significant effect of stress and rotenone interaction (F (1,20) = 6.25, P = .02) but no significant effect of stress or rotenone only) and cell count analysis of n-tyrosine positive cells (two-way ANOVA showed significant effect of stress (F (1,20) = 10.69, P < .00) but no significant effect of rotenone or interaction) in the lamina propria. (E) Pro-inflammatory cytokine IL1β expression using western blot analysis. Two-way ANOVA showed significant effect of stress (F (1,22) = 9.08, P = .01) but no effects of rotenone or interaction. (F) Representative images of enteric glial cells (GFAP+) expression and alpha-synuclein (A-SYN) expression in the myenteric plexuses. Graphs (G, H) show optical density analysis of GFAP expression in the lamina propria (Two-way ANOVA showed significant effect of stress and rotenone interaction (F (1,22) = 5.43, P = .03) but no significant effect of stress or rotenone alone) and myenteric plexuses (Two-way ANOVA showed significant effect of stress (F (1,22) = 17.49, P < .00) and rotenone (F (1,22) = 53.49, P < .00) but not significant interaction). Graph (I) represent optical density analysis for a-syn expression in the myenteric plexuses (Twoway ANOVA showed significant effect of rotenone (F (1,22) = 21.17, P < .00) but no significant stress effect or stress and rotenone interaction). Data are mean + SEM; *p < .05, **p < .01, ***p < .001; n = 7 mice/group (except RS + rotenone group (n = 5)) for all panels. Scale bar in B and F represents 50 μm and applies to all panels in B and F. RS = restraint stress, OD = optical density, GFAP = Glial fibrillary acidic protein, A-SYN = alpha-synuclein.
(caption on next page) H.B. Dodiya et al. Neurobiology of Disease xxx (xxxx) xxxx cells in each category (i.e., resting, activated and dystrophic/phagocytic microglia). Two-way ANOVA and followed by post-hoc analysis showed (Fig. 5C , Table S5 ): 1) control mice had higher numbers of resting microglia compared to all other groups (rotenone and stress interaction: F[5, 28] = 39.57, P < .0001, post-hoc P < .0001), 2) rotenone treatment increased the numbers of dystrophic/phagocytic microglia compared to control mice (for rotenone: F[5, 28] = 25.96, P < .0001, post-hoc P = .0060), 3) RS significantly reduced the number of resting microglia (P < .0001) and significantly increased the number of activated microglia (rotenone and stress interaction: F[5, 28] = 11.13, P = .003, post-hoc P < .0001) compared to controls, 4) RS + rotenone had significantly fewer resting microglia compared to control and rotenone groups (P < .0008), more activated microglia compared to control (P < .05), and more dystrophic/phagocytic microglia compared to control and RS groups (P < .01). These data support an increased microglial-neuroinflammation in the substantia nigra of RS + rotenone treated mice (Fig. 5C , Table S5 ).
FJ-C+ dying cells in SN
Visualization of cell death marker (FJ-C) in the SN showed a minimal number of dying cells in the control and RS groups (Fig. 5D) . In contrast, a higher number of dying cells were observed in the SN of RS + rotenone (Fig. 5D ). Additionally, most of the FJ-C+ cells in the SN of RS + Rotenone showed positive co-localization with TH+ marker suggesting only RS + Rotenone mice showed dying dopamine cells.
LPS reactivity in SN
Visualization of bacterial endotoxin marker LPS showed no LPS + ve structures in the SN of control groups. Rotenone treatment showed some LPS reactivity in the SN. In contrast, RS and RS + rotenone groups showed higher LPS reactivity in the SN compared to controls (Fig. 5E, Fig. S5 ).
TLR4 reactivity in Striatum
Furthermore, the bacterial endotoxin ligand toll-like receptor 4 (TLR4) was also assessed in the striatum of these mice. Visualization under confocal microscope showed minimal expression of TLR4+ cells in control and rotenone-treated mice whereas higher TLR4 immunoreactivity was observed in the striatum of RS + rotenone treated mice compared to other groups (Fig. S6) .
TH+ dopamine cells in SN
Immunohistochemistry for TH reactivity showed fewer TH+ cells in rotenone and RS + rotenone compared to controls (Fig. 5F ). Stereological analysis showed significantly lower TH+ cell in rotenonetreated mice (F[5, 28] = 49.63, P < .00) but there was no effect of stress nor a stress by rotenone interaction (P > .05) (Fig. 5G ). Post-hoc analysis showed significantly fewer TH+ cells in the SN of rotenonetreated mice compared to controls (P < .00) and fewer cells in RS + rotenone compared to RS alone (P < .00).
Dopamine and metabolites in Striatum
Dopamine (DA) cell loss in the SN results in less DA output in the striatum due to degeneration of nigro-striatal innervation; thus, we evaluated concentrations of DA and its metabolites DOPAC and HVA in the striatum (Fig. 5H,I,J) . The DA concentration was significantly affected by rotenone (F[5, 28] = 10.52, P < .00), stress (F[5, 28] = 8.48, P = .01), as well as a rotenone by stress interaction (F[5, 28] = 8.57, P = .01) ( Fig. 5H ). Post-hoc comparison showed significantly lower striatal DA in the RS + rotenone compared to all other groups (P < .01). Levels of striatal DOPAC showed no significant changes (p > .05) (Fig. 5I ). Levels of striatal HVA was significantly impacted by stress (F[5, 28] = 12.46, P = .00) but were not affected by rotenone or a stress by rotenone interaction (p > .05) (Fig. 5J ). Posthoc analyses showed significantly lower striatal HVA in RS + rotenone mice compared to rotenone-treated group (P < .01). These data support a significantly reduced DA availability at the striatal terminals in RS + rotenone group. Visualization of TH immunohistochemistry showed prominent reduction of TH intensity in the RS + rotenone compared to the other groups (Fig. S6 ).
Restraint stress potentiated rotenone-induced effects on behavior
There were no significant differences in rotarod performance at baseline or after six weeks of RS (week 9) ( Fig. 6A ). There was a significant effect of interaction between time and treatments (F[63, 72] = 2.654, P = .03) as well as significant effect of matching subjects (F[28, 63] = 1.982, P = .03). A post hoc comparison showed significantly reduced rotarod performance in RS + rotenone treatment compared to RS alone (P < .05) at week 15.
The adhesive removal test (Fig. 6B ) was carried out at week 14 to assess sensory and motor impairment. Performance in the adhesive removal test was significantly influenced by stress (F[5, 28] = 28.59, P < .00), rotenone (F[5, 28] = 50.63, P < .00), as well as a stress by rotenone interaction (F[5, 28] = 18.93, P < .00). Post-hoc analysis showed that the RS + rotenone group took significantly longer time to remove the adhesive stickers compared to RS and rotenone groups alone (P < .00).
The hanging grip test was carried out to measure muscle strength at week 14 (Fig. 6C ). Muscle strength was significantly impacted by rotenone (F[5, 28] = 14.39, P < .00) but there was no effect of stress or a stress by rotenone interaction (P > .05). Post-hoc analysis showed that RS + rotenone mice showed lack of muscle strength compared to RS alone (P < .01).
Evidence to support gut-brain axis involvement in our proposed model
In order to better understand the interaction between periphery and central compartments, we performed a Pearson correlation between the markers of interest (Fig. 7) . While correlation does not equal causation, this correlation analysis does allow us to infer potential interactions. We observed significant positive correlation between dystrophic/phagocytic microglia cell counts in the SN and decreased colonic ZO-1 tight junction protein expression (r = −0.489, P = .011, Fig. 7A) , increased systemic levels of LPS (r = 0.523, P = .006, Fig. 7B ) and increased relative abundance of Akkermansia (mucin degrading, Gram negative bacteria) (r = 0.437, P = .026, Fig. 7C ). Also, relative abundance of Akkermansia inversely correlated with muscle strength performance on Representative images of resting microglia, activated microglia and dystrophic/phagocytic microglia, (C) graph shows estimated Iba1+ cells in the SN based on their morphology characteristics. Two-way ANOVA showed significant differences in microglia morphology between groups. (D) Representative immunofluorescence images of FJ-C+ dying cells in combination with TH+ dopamice cells in the SN. (E) Representative images of LPS reactivity in the SN. (F) Representative images of TH+ dopamine cells in the SN and (G) stereological estimates (two-way ANOVA showed significant effect of rotenone (F[5, 28] = 49.63, P < .00) but no significant stress effect or interaction). (H, I, J) HPLC measured levels of dopamine and dopamine metabolites in the striatum. Two-way ANOVA showed that striatal dopamine levels were significantly affected by rotenone (F (1,22) = 10.52, P < .00), stress (F (1,22) = 8.48, P = .01), as well as a rotenone by stress interaction (F (1,22) = 8.57, P = .01) while DOPAC level showed no significant changes and HVA levels were significantly impacted by stress (F (1,22) = 12.46, P = .00) but no significant effect of rotenone or interaction. Data represent mean + SEM; *p < .05, **p < .01, ***p < .001; n = 7 mice/group (except RS + rotenone group (n = 5)) for all panels. RS = restraint stress, FJ-C=Fluorojade-C, LPS = lipopolysaccharides, TH = Tyrosine hydroxylase, DOPAC = Dopamine carboxylase, HVA = homovanillic acid. the hanging grip test (r = −0.575, P = .002, Fig. 7D ). We also observed positive correlation between fecal butyrate levels and striatal DA levels (r = 0.450, P = .024, Fig. 7E ).
Discussion
The current study demonstrated that stress-induced disruption of intestinal barrier integrity, dysbiosis and endotoxemia promotes microglial activation, neuro-inflammation, DA loss and the PD phenotype in rotenone model of PD and these effects were not due to increased systemic and brain exposure to the neurotoxin rotenone. Thus, to our knowledge, our study is the first to provide unique and novel compelling evidence that a dysfunctional microbiota-gut-brain axis can potentiate the PD phenotype and pathology.
Intestinal hyper-permeability can induce systemic inflammation leading to the inflammatory responses in the brain and that should further exacerbate neuronal loss in patients with PD similar to what we observed in our rotenone model. A similar intestinal hyper-permeability model driving CNS neuroinflammation has been proposed in other neuropsychological disorders like major depression (Maes et al., 2008) .
Stress negatively affects intestinal barrier function (Zheng et al., 2013; Lennon et al., 2013; Soderholm et al., 2002) . In agreement with this literature, we observed that chronic stress induced by six weeks of daily RS caused significant increase in urinary sucralose/lactulose ratio which is a marker of primarily increased colonic permeability . This observed leakiness to LPS appeared to be due to disruption of key tight junctional proteins in colonic tissue: ZO-1, occludin, and claudin-1, similar to data observed by others (Zheng et al., 2013) . Rotenone alone reduced ZO-1 integrity as reported previously by our group (Perez-Pardo et al., 2018) . While stress alone and rotenone alone disrupted some of the tight junction proteins, only RS + rotenone disrupted all three major tight junction proteins which could explain why RS + rotenone caused severe enough colonic hyperpermeability to result in increased level of plasma LPS (endotoxemia). Individual tight junction protein level did not correlate with LPS level significantly. This is not necessarily surprising because disruption of single protein does not always lead to disruption of intestinal barrier severe enough to cause endotoxemia and typically an aggregate of disruption of several tight junction proteins is required for severe enough leak to cause elevated plasma LPS.
Several studies have shown that stress impacts intestinal microbiota composition. For example, Bailey and colleagues report significantly lower levels of Lactobacilli following stress in non-human primates (Bailey & Coe, 1999) . They also report that reduced abundance of certain intestinal microflora correlated with stress-indicative behaviors but did not correlate with cortisol suggesting that chronic stress-induced biological effects may not solely be due to changes in cortisol. One study showed improved behavior, cognition and biochemical aberration in the brain following oral Lactobacillus administration in a rodent model of chronic stress (Liang et al., 2015) . We also observed a reduction in the relative abundance of genera Lactobacillus following six weeks of RS; however, there was no difference in the relative abundance of genera Lactobacillus between RS and none-RS groups at week 15. This might be the consequence of daily gavage-induced stress from week 9 to week 15 in all groups. In addition to Lactobacillus, we observed an increased relative abundance of Clostridiales (family) in the RS group compared to control mice at week 15 which is in agreement with other reports (Galley et al., 2014; Bailey et al., 2011; O'Mahony et al., 2009) . Although Bailey and colleagues report a lower relative abundance of Bacteroides due to stress (Bailey et al., 2011) , our data did not show any changes in the levels of Bacteroides with RS.
Rotenone treatment reduced the relative abundance of Actinobacteria (phylum) and Coriobactericeae (family) compared to controls. Our data suggest that RS in combination with rotenone creates an intestinal profile that is uniquely distinct from stress or rotenone alone. For example, compared to RS alone, RS + rotenone significantly reduced the relative abundance of Firmicutes and Actinobacteria and significantly increased the relative abundance of Verrucomicrobia at the phylum level. In general, the RS + rotenone microbiota profile showed decreased putative "anti-inflammatory" bacteria as well as an increase in putative "pro-inflammatory" bacteria and these changes may contribute to neuroinflammation and neurodegeneration observed when RS and rotenone are combined.
One consequence of intestinal hyper-permeability is immune activation and oxidative stress. Indeed our data showed increased n-tyr-osine+ cells in the lamina propria and enteric glial expression in the myenteric plexuses supporting the presence of pro-inflammatory state in the colon of mice with disrupted intestinal barrier integrity and hyperpermeability. While there was no additive effect of oxidative stress (n-tyrosine) due to RS + rotenone, there was evidence that the combination promoted enteric glial activation (increased GFAP reactivity) in the myenteric plexuses of the colon. 6 . Restraint stress (RS) in combination with rotenone promotes behavioral deficits. (A) Rotarod behavior at baseline, after six weeks of RS (week 9), and followed by six weeks of RS ± rotenone (week 15) (rmANOVA showed significant time and treatment interaction (F (6,44) = 2.65, P = .03)). (B) Adhesive removal test at week 14 (Two-way ANOVA showed significant effect of stress (F (1,22) = 28.59, P < .00), rotenone (F (1,22) = 50.63, P < .00) and stress and rotenone interaction (F (1,22) = 18.93, P < .00)). (C) Hanging grip test at week 14 (Two-way ANOVA showed significant effect of rotenone (F (1,22) = 14.39, P < .00) and no effect of stress nor an interaction). The data are presented as mean + SEM. *P < .05, **P < .01, ***P < .001. n = 7 mice/group (except RS + rotenone group (n = 5) at week 15) for all panels. RS = restraint stress. Several animal and in vitro studies have used LPS to promote PD phenotype (Block & Hong, 2005; Qin et al., 2007; Hoban et al., 2013; Liu & Bing, 2011) . We observed increase in LPS reactivity of the SN in stress groups (RS and RS + rotenone) suggesting that endotoxemia, either due to intestinal hyper-permeability or intestinal microbiota dysbiosis, could allow bacteria/bacterial products such as endotoxins into the SN brain region critical for PD pathogenesis. Endotoxemia associated disrupted blood brain barrier (as shown (Banks et al., 2015) ) could facilitate the dysfunction of the midbrain. Bloor brain barrier integrity in the future studies using techniques appropriate to test its permeability is warranted. LPS is a primary ligand for TLR4 (Erridge et al., 2002; Latorre et al., 2010) . Several studies have shown that stress increases TLR4 activation in the brain (Garate et al., 2011; Garate et al., 2013; MacDowell et al., 2014) and that TLR4 is elevated in the brain of PD patients (Drouin-Ouellet et al., 2014) . It is possible that this is due to, at least in part, to stress-induced changes in gut hyperpermeability/ dysbiosis and endotoxemia (Garate et al., 2011; Garate et al., 2013) . Similar to these findings, we also observe higher TLR4 reactivity in the midbrains of stress groups. LPS is a well-characterized neurotoxin responsible for dopamine cell degeneration in the SN (Herrera et al., 2000) ; thus, chronically elevated levels of systemic LPS (as shown in our study) could contribute to brain inflammation and neurodegenerative processes via a mechanism including TLR4 signaling.
The combination of RS + rotenone appears to have important consequences in the brain. For example, RS potentiated rotenone-induced effects on the number of resting microglia and DA and HVA concentration in the striatum. Similarly, activated microglia due to stress-induced higher inflammatory response and were associated with a higher rate of death of dopaminergic neurons in the SN in stress+LPS mice (de Pablos et al., 2014) . Functionally, we were able to observe that the adhesive removal test appeared to be most sensitive to combined effects of stress and rotenone suggesting that sensory systems could be highly impacted by stress and stress-induced gut derived pro-inflammatory state. To further support the hypothesis that gut-derived inflammation promote neuro-inflammation, we performed series of correlation analysis (Fig. 7) and found that the microglia phenotype (especially dystrophic/phagocytic microglia numbers) in SN is positively correlated with markers of disrupted colonic barrier integrity, serum LPS and relative abundance of Akkermansia. Behaviorally, the outcomes from the adhesive removal test appear to be correlated to TH + DA cells in the SN and DA concentration in the striatum. Our findings begin to provide evidence for a role for disrupted gut-brain axis in pathogenesis of PD. Further studies are needed to determine whether there is a causal link between gut-brain axis and PD. Our data now provide a scientific rationale for conducting longitudinal and interventional studies to look for the causal link.
The data observed in the current study support what we have observed in human PD patients. Our previously published data show that PD subjects, including newly diagnosed PD subjects, have evidence of microbial dysbiosis , intestinal hyper-permeability (Forsyth et al., 2012) , and microbial translocation (Forsyth et al., 2012; Pal et al., 2015) . The exact cause of intestinal hyperpermeability in PD patients is unknown, but our current study suggests that events such as stress and or dysbiosis that initiate intestinal hyperpermeability may induce low-grade chronic intestinal and neuro-inflammation. This low-grade chronic inflammation could contribute to neurodegeneration as has been proposed in depression (Maes et al., 2008) . We propose that higher TLR4 expression in the peripheral blood mononuclear cells and the brains of PD patients (Drouin-Ouellet et al., 2014) could be caused, at least in part, by intestinal dysbiosis and/or gut hyperpermeability. Future interventional clinical studiessuch as use of microbiota directed intervention, are needed to directly answer these questions and establish the causal link between gutderived inflammation, upregulated TLR-4 signaling and neuro-inflammation in PD patients.
In summary, we have provided new evidence that stress-induced intestinal hyper-permeability and microbiota dysbiosis promote an intestinal pro-inflammatory milieu, peripheral (and SN) endotoxemia, neuroinflammation, and neurodegeneration in a low-dose, oral rotenone-induced PD mouse model. Future mechanistic studies could help further understand the exact role of stress-mediated gut dysfunction in neurodegeneration in the SN. The current study adds significant new support for the possible role of the microbiota-gut-brain axis in PD pathogenesis.
Materials and methods
Animals and experimental protocol
Young adult (6-8 weeks) male C57BL/6 mice were employed for this study. We chose to study only male mice because incidence of PD is biased towards male (Wooten et al., 2004; Hirsch et al., 2016) . Animals were purchased from Harlan (Indianapolis, IN) . We elected to house 3 or 4 mice in each cage. The primary question for the current study was if stress exacerbates rotenone-induced PD pathology. It is now well established that housing rodents individually results in stress (Voikar et al., 2005; Martin & Brown, 2010; Fone & Porkess, 2008; Lukkes et al., 2009; Ros-Simo & Valverde, 2012) compared to co-housing. Thus, we elected not to singly house mouse to avoid co-founders that would impair data interpretation. Only mice from the same experimental groups were housed together in order to avoid cross-contamination of stool microbiome that could clearly mask the microbiota-mediated readout(s) as reported in our study. Both RS and non-RS group mice were housed and handled in a specific pathogen free (SPF) environment either in the SPF mice facility or approved behavior facility room. Experimenters followed the same exact conditions, including the usage of PPE (personal protective equipment; especially hand gloves), which was changed between handling of mice from different groups to avoid any cross-contamination. In addition, the fecal samples were collected by forceps (cleaned with alcohol before each use) to avoid any crosscontamination. Thus, there is little to no possibility of only one group exposing to specific environmental microbes leading to their altered fecal microbiome as observed in our study.
Animal experiments and maintenance were approved by the IACUC of the Rush University Medical Center (Chicago, IL). The study involved a total of 28 mice that were randomized into four groups (n = 7 in each): vehicle, rotenone, RS, and RS + rotenone. Mice were acclimated to the facility for two weeks prior to initiation of the study (Week −2 to 0). Mice underwent baseline training and testing for the rotarod for three weeks (Week 0 to 3). Restraint stress was initiated during week three and continued for the duration of the study. After six weeks of RS, a test for gut permeability was conducted and stool was collected for microbiota analysis. Rotenone (or vehicle) was administered daily from week 9 through week 15 followed by behavioral tests, permeability assay, stool collection, sacrifice and tissue harvest during week 15 (Fig. 1A) . . 7 . Pearson correlations support the possible gut-brain axis involvement in leaky gut-induced exacerbated PD phenotype in a rotenone PD mice model. (A) ZO-1 integrity score was significantly inversely correlated with dystrophic/phagocytic microglia counts in the SN. (B) Plasma LPS levels and (C) bacterial taxa Akkermansia (mucin degrading gram-bacteria) were significantly positively correlated with dystrophic/phagocytic microglial counts in the SN. (D) Relative abundance of Akkermansia (mucin degrading gram-bacteria) were significantly inversely correlated with hanging grip test behavior data. (E) Fecal butyrate levels were significantly positively correlated with striatal DA concentrations.
Fig
Rotenone gavage
For rotenone intoxication, mice received oral gavage of a freshlyprepared (10 min prior to gavage) rotenone solution (or vehicle control) at a dose of 10 mg/kg/day body weight, suspended in vehicle (4% carboxymethylcellulose and 1.25% chloroform) (Pan-Montojo & Funk, 2010).
Chronic restraint stress (RS) protocol
For RS administration, mice (n = 14 total) were kept in 50 mL conical tubes for 2 h/day (5 days/week) throughout the study. RS was performed between 10:00 am-3:00 pm at different times to minimize acclimation to the daily RS treatment. The tubes had multiple holes (approximately 0.5 cm size) to allow airflow and also prevent hyperthermia. Control mice were housed alone in a new cage for two hours without food and water. Fecal pellets for each mouse were collected during these two hours. Immediately after RS, mice were returned to the home cage and had access to food and water ad libitum. To confirm the effectiveness of the RS protocol, four parameters were recorded: 1) weekly body weight, 2) weekly 24 h food intake (starting at week 7), 3) weekly fecal output (total weight of stool pellets) during RS session, and 4) urinary cortisol was measured after six weeks of chronic RS before rotenone administration.
Behavior studies
Three different behavioral experiments were conducted including: 1) rotarod for motor impairment, 2) adhesive removal test for sensory and motor impairment, and 3) hanging grip test for muscle strength. 1) Rotarod test was performed at three different times (baseline (week 3), week 9, week 15). During this procedure, mice were placed on rod with a speed of 2 rpm and the speed was gradually increased to 90 rpm during the 90s trial. Time to fall was recorded. Three trials were performed for each mouse with a 15 min interval between trials. 2) Adhesive removal test was performed at week 14. During the test procedure, animals were allowed to move freely in a clean cage for one minute prior to the test to allow for acclimation. Stickers were applied to the front paws with gentle pressure and mice were then placed back into the testing cage and time for each animal to remove both stickers was recorded. Three trials were recorded for each mouse with a minimum of a 15 min interval between each trial. 3) Hanging grip test was performed at week 14. During this procedure, mice were kept on a wire mesh for one minute before the test procedure for acclimation. The wire mesh was then inverted and total hang time was recorded for each mouse before they fell into a cage below. Three trials were recorded for each mouse with 15 min intervals between trials.
Intestinal permeability and markers of microbial translocation (MMT) measurements
Gut permeability was measured using an established protocol (Summa et al., 2013) at three different times (baseline (week 3), week 9, week 15). In brief, mice were fasted overnight prior to the permeability test to prevent confounding factors associated with dietary sugar intake. During the test, mice were gavaged with a solution of non-absorbable, poorly digestible sugar (sucralose, lactulose, mannitol, sucrose) and given a subcutaneous injection of saline (0.9%) to promote urine production. Mice were then placed into individual metabolic chambers for five hours to collect urine. Gas chromatography was performed on the urine samples to measure excreted levels of sugars during the five hours. Urinary data were recorded as percentage excretion of oral dosage. Fecal pellets were also collected and stored at -80°C for future analysis. We used sugar cocktail markers to assess intestinal permeability because: (Norden et al., 2015) unlike other markers such as FITC-Dextran, it provides an opportunity to identify the region of the gut where hyperpermeability primarily occurs. For example, mannitol is primarily absorbed in the proximal small bowel and with a molecular weight of 182 Da is a marker for both pores and leak pathways. Lactulose and sucralose are both larger size molecules and are markers of leak pathway only. Both lactulose and sucralose can be absorbed in both small and large intestine but since lactulose can be fermented by colonic bacteria, it primarily represents small intestinal permeability marker. Thus, if urinary mannitol/lactulose are normal while urinary sucralose is elevated, it represents that disruption of intestinal barrier is primarily through leak pathway and is primarily is in the colon. Furthermore, unlike FITC marker, sugar cocktail can be used to assess intestinal permeability in both rodents and human. Importantly, our hypothesis of stress-induced hyper-permeability and its role in PD pathogenesis was based on our groups' published data that intestinal leak in PD patients is primarily in the colon with significantly elevated urinary sucralose and normal mannitol and lactulose levels (Forsyth et al., 2012) and Sucralose/lactulose ratio ; (Sekiyama et al., 2012) unlike FITC marker, sugar cocktail can be used to assess intestinal permeability in both rodents and human.
Levels of markers of microbial translocation (MMT) were measured using plasma samples of the mice collected during sacrifice. Lipopolysaccharides (LPS) (N384, Pyrogent 5000) and LPS binding protein (LBP) (HK205, Hyarlt Biotech) were measured using ELISA kits according to the manufacturer protocol.
Sacrifice and tissue collection
Necropsy was performed under anesthesia as approved by Rush IACUC#14-011. Blood (~500 μL) was collected by cardiac puncture and stored on ice to collect plasma. After blood collection, animals were perfused with cold saline. The descending aorta was clamped using hemostatic forceps to perfuse the upper body. Brain and intestinal tissue samples were harvested and stored either in optimal cutting temperature (OCT) media (4583, Tissue-tek), as fresh frozen tissue for proteomic analyses, or in 4% paraformaldehyde (overnight) for histology.
Immunohistochemistry
Brain sections were cut using a microtome at 40 μm thickness and sections were stored in cryoprotectant. Colon samples were cut at 6 μm thickness using a cryostat (CM3050, Leica) and were mounted on glass slides for analysis. Histology was performed on paraformaldehyde fixed brain samples using an established method (Dodiya et al., 2010) and colon samples according to an established protocol (Engen et al., 2017) . In brief, sections were washed with phosphate buffer saline (PBS) for 30 min. An endogenous sodium peroxidase block was performed using sodium periodate solution for 20 min. Following peroxidase blocking, sections were washed multiple times in PBS and incubated in serum blocking solution for an hour (2% BSA and 3% serum targeting host of the secondary antibody). Primary antibodies to 617, 300; Invitrogen) , occludin (1:200; 331,500; Life technology), 717, 800; Invitrogen) , Millipore), αsyn (1:200, LB509, Invitrogen) , and GFAP (1:500; Z0334, DAKO) were used for the colon tissue while antibodies to Iba1 (1:500; 019-19,741, Wako), TH (1:1000; AB152, Millipore), LPS (1:250; ab35654, Abcam), and TLR4 (1:150; ab13556, Abcam) were used for the brain tissue staining. Sections were kept in the primary antibody solution overnight at room temperature. The next day, sections were washed and processed with secondary antibody. Immunofluorescence staining was performed using specific fluorescence secondary antibodies (1:400; A21202, A31572, A21432; Life Technologies) while immunoperoxidase staining was performed using biotinylated secondary antibodies (1:200; BA1000, BA2000; Vector Laboratories). Immunoperoxidase sections were treated with actin-biotin complex incubation before developing a color reaction in the presence of DAB chromogen and hydrogen peroxide. Counterstaining was performed using DAPI (1:10,000; Invitrogen) for immunofluorescence slides and hematoxylin (SH26-500D, Fisher) for immunoperoxidase stained slides. Dying cells in the SN were stained using Fluorojade-C (FJ-C) marker as per manufacturer protocol. Once completed, immunofluorescence sections were cover-slipped using aquamount (4583, Tissue-Tek) and stored at 4°C for confocal microscopic analyses. Immunoperoxidase stained sections were processed through different grades of alcohol (0%-99%) and then incubated in xylene for 15 min before applying a coverslip using vectastat 60 mounting media (Life technology).
Western blot analysis
IL1-β (1:5000; ab9722; Abcam) was evaluated using a Western blot. In brief, tissue was homogenized and followed with bicinchoninic acid assay (BCA assay) to measure total protein concentration. Equal amounts of protein were loaded in each lane of the gel (10% separating acrylamide gel) and separated using electrophoresis. Proteins were then transferred to a nitrocellulose membrane and bands were visualized with an Odyssey infrared scanner after immunolabeling with the respective primary antibodies followed by an infrared specific fluorophore-tagged secondary antibody.
Cytokine antibody array
Mouse Cytokine Antibody Array C1 was utilized to detect cytokines/ chemokines level (AAM-CYT-1-8, RayBiotech, GA) as per manufacturer's protocol. In brief, colon tissue samples were homogenized in a cell lysis buffer (+protease inhibitor) provided by the manufacturer. BCA assay was performed to measure total protein concentration. N = 3/4 cases in equal protein concentrations were pooled to run two blots per group. Total of 300 μg of protein was incubated onto each membrane for an overnight at 4°C after blocking the membrane with the blocking buffer. Next day, membranes were washed and incubated for biotinylated antibody cocktail (1.5 h), followed by washes and HRPstreptavidin incubation (2 h). Chemiluminescence was detected and scanned to perform densitometric analysis using ImageJ. Background was subtracted and data were normalized per blot using positive controls to generate the relative density reads. These data then transformed into Log2 and analyzed using Two-way ANOVA. Heatmap was generated using R software for the Log2 data.
Microscopic analysis -cell counts
TH+ cells were evaluated in the left hemisphere of the SN using stereoinvestigator software (MBF Bioscience) (Dodiya et al., 2010) . In brief, levelmatched SN sections (n = 5) were selected per case to perform the stereology. For each section, the SN was outlined under low magnification (4×). Using grid size (175μmx175μm) and frame size (80μmx80μm), sections were evaluated under high magnification (60×). The estimated number of cells and total estimated volume were recorded from the Stereology software. Data were reported as estimated neuronal density (estimated number of cells in total volume of outlined SN = cells/mm 3 ).
Iba1+ microglial cells in the SN were analyzed using Image-J software (Image J 3.1, NIH) blinded. Level-matched SN sections (n = 3) were selected to evaluate the Iba1+ microglial cells. Using light microscope (BX61, Olympus), five images per section were taken randomly focusing on the SN region under 60 × 1.6 magnification. In each image, 16,925μm 2 area was evaluated for Iba1+ cells. Images were processed and uploaded in Image-J and Iba1+ cells were counted according to their morphology characteristics. Cell morphology was assessed using three different phenotypes as published: (Norden et al., 2015; Kopp et al., 2013; Streit et al., 1999; Wilkinson et al., 2013) 1) resting (normal ramification and smaller cell body), 2) activated (higher ramification and larger cell body) and 3) dystrophic/phagocytic (two or less processes with larger cell body, amoeboid shape).
Microscopic analysis -optical density (OD) measurements
Image J software was used to measure the intensity of N-tyrosine expression in the lamina propria, GFAP+ enteric glial cells expression in the lamina propria, GFAP+ enteric glial cells in the myenteric plexuses, and α-syn expression in the myenteric plexuses of the colon samples. Fluorescence images were captured using a confocal microscope under higher magnification. Images were processed for compatibility with Image J software and regions of interest were selected to measure the intensity. Background was measured and subtracted from the measured readings. Data were recorded as mean intensity measures.
Microscopic analysis -integrity score measurements for tight junction proteins
Quantification of the tight junction barrier integrity was performed as published (Engen et al., 2017) using scale (0-3) for tight junction protein immunofluorescence sections (0 = no immunofluorescence, 1 = very light and discontinuous immunofluorescence, 2 = intense and discontinuous immunofluorescence, 3 = smooth continuous and well organized immunofluorescence). Two sections were used for imaging analyses. The slides were randomized and coded to collect fluorescence images to avoid bias. A minimum of twenty crypts were analyzed and the average values were collected for analysis.
HPLC measurements for DA and its metabolites
Striatal DA, DOPAC, and HVA were quantified previously described (Khasnavis et al., 2014; Rangasamy et al., 2018) . Briefly, striatum from half of the brain was collected and immediately frozen using dry ice and stored at -80°C until the analysis. During HPLC measurements, striatal tissues were sonicated in perchloric acid (0.2 M) containing isoproterenol and left on ice for 20 min. The resulting homogenates were centrifuged at 10,000 g for 15 min at 4°C. After centrifugation, 10 μL of supernatant was injected onto an Eicompak SC-3ODS column (HPLC-ECD System, JM Science, EiCOMHTEC-500) and analyzed per manufacture protocol. Standard peaks were generated using 10 μg of DA, DOPAC, and HVA to calculate the concentrations in each sample. Data were presented in ng/kg of tissue.
Microbiota sequencing using 16S-rDNA technique
Total DNA was extracted from mice feces utilizing FastDNA beadbeating Spin Kit for Soil (MP Biomedicals, Solon, OH) and processed using high-throughput Illumina amplicon sequencing at Argonne National Laboratory, as described previously (Engen et al., 2017) . Raw FASTQ files for each sample were merged using the software package PEAR (Pair-end-read merger) (V0.9.8) (Schmieder & Edwards, 2011) . Merged reads were quality trimmed and sequences shorter than 250 bases were discarded (CLC genomics workbench (V10.0, CLC Bio, Qiagen, Boston, MA). Sequence data were screened for chimeras, rarefied (25,000), and operational taxonomic units (OTU) classified, as described previously (Engen et al., 2017) . A biological observation matrix (BIOM) (McDonald et al., 2012) was generated at taxonomic level from phylum to genus ("make OTU table" algorithm) and analyzed using software packages Primer7 (Clarke, 1993) and the R programming environment (Team, 2013) .
Alpha diversity indices and Beta diversity were used to examine changes in microbial community structure between mice fecal group samples. To study differences in overall microbial community composition between fecal samples, pairwise Bray-Curtis dissimilarity (nonphylogenetic) metrix was generated using Primer7 software package and used to implement analysis of similarity (ANOSIM) calculations. ANOSIM was performed at the taxonomic levels of phylum, family, and genus, using square-root transformed data.
Within the software package QIIME (Caporaso et al., 2010) , differences in relative abundances of individual taxa, between defined groups, were analyzed for significance using Kruskal-Wallis test, generating both P-value and a Benjamini-Hochberg false-discovery rate (FDR) corrected P-value. Significant taxa differences were reported at FDR-P < .05 or taxa relevant to this study, with P < .05 values. Furthermore, mice fecal group sample's community functional predictions were performed using PICRUSt (Phylogenetic Investigation of Communities by Reconstruction of Unobserved States) (Langille et al., 2013) and differences in Kyoto Encyclopedia of Genes and Genomes (KEGG) ortholog (KO) abundances between groups were identified (Kanehisa & Goto, 2000) . The raw sequence data (FASTQ files) were deposited in the National Center for Biotechnology Information (NCBI) Sequence Read Archive (SRA), under the BioProject identifier PRJNA454894.
Fecal short chain fatty acid measures
SCFAs were extracted and quantified by GC-MS for stool samples from 28 mice. Absolute quantities of acetic, propionic, isobutyric, butyric, isovaleric, and valeric acids were determined by using spiked heavy labelled internal standards. Briefly, 80 mg frozen pellet, 0.5 mL of cold 0.1 M HCl containing 200 μg/mL of 13C2-acetic acid and 10 μg/ mL of 13C4 sodium butyrate were added. Samples were vigorously shaken on a vortex plate for 15 min and then sonicated for 10 min in cold water bath. Then the samples were centrifuged at 15,000 g for 15 min at 4°C. Supernatants (250 μL) were recovered, and added to 0.5 mL MTBE, followed by vortexing for 10 s. The top MTBE layer was recovered after centrifugation at 2000 rpm for 2 min, and stored at 4°C until analysis. The MTBE extract (1 μL) of SCFAs were injected into a Trace 1310 GC coupled to a Thermo ISQ-LT MS, at a 5:1 split ratio. The inlet was held at 240°C and transfer line was held at 240°C. SCFA separation was achieved on a 30 m DB-WAXUI column (J&W, 0.25 mm ID, 0.25 μm film thickness). Oven temperature was held at 80°C for 0.5 min, ramped at 10°C/min to 175°C, then ramped to 240°C at 40°C/min, and held at 240°C for 3 min. Helium carrier gas flow was held at 1.2 mL/min. SIM mode was used to scan ions 45, 60, 62, 73, 74, 76, 87, 88, 92 at a rate of 10 scans/s under electron impact mode. Acetic, propionic, isobutyric acids were quantified by IS -13C2-acetic acid. Butyric, isovaleric, and valeric acids were quantified by IS -13C4 sodium butyrate.
Rotenone measurements in the brain and liver
Brain rotenone levels were measured at Mass Spectrometry, Metabolomics and Proteomics Facility at the UIC. In brief, rotenone was dissolved in MS grade H2O: Acetonitrile (1:4, v:v). A standard curve was created with 7 points: 200 fg, 500 fg, 1 pg, 5 pg, 15 pg, 50 pg and 100 pg. Brain samples were stored at -80°C until use. Brain was placed into a bead-beating tube and 400 μL of acetonitrile was added and tissue beat for 2 × 10 seconds. Samples were centrifuged at 14000 g at 4°C for 10 min and 200 μL of supernatant were collected. Samples were dried with N2 and reconstituted with 100 μL H 2 O: Acetonitrile (1:4, v:v).The LC/MS analysis was performed on AB Sciex Qtrap 5500 MS coupled to Agilent 1290 UPLC system. All samples were analyzed by Phenomenex HPLC C18 Column, 100 Å, 2.6 μm, 2.1 mm × 50 mm coupled to an Agilent 1290 UPLC system, which was operated at a flow rate of 400 μL/min. A gradient of buffer A (H20, 0.1% Formic acid) and buffer B (Acetonitrile, 0.1% Formic acid) was applied as: 0 min, 1% of buffer B; increase buffer B to 50% in 3 min; 50%-90% in 2 min; Kept B at 100% for 3 min. The column was equilibrated for 2 min at 1% B between the injections. The column temperature was 40°C and the autosampler was kept at 4°C. The MS condition of analytes was optimized on tuning mode; the results are listed in Supplemental Fig. 3 . The quantification was achieved using area of monitored transitions. All the samples were analyzed by triplicate.
Liver rotenone levels were measured by LC-MS. The service was performed by Dr. Yue-Ting Wang at the Mass Spectrometry Core in Research Resources Center of University of Illinois at Chicago. In brief, Initial solution of rotenone was prepared at 1 mg/mL in acetonitrile (ACN). It was then diluted to 10 μg/mL, 100 ng/mL, 10 ng/mL, 5 ng/ mL, 1 ng/mL, 0.2 ng/mL, 0.1 ng/mL, and 0.05 ng/mL as the standard solutions used to prepare the standard curve. All stock solutions were stored at -20C. The mixture solvent (1.2 mL) with MeOH and water (1∶1, v/v) was added to the frozen liver tissues (about 100 mg), which were then homogenized (30 frequency) for 2 min. The suspension was centrifuged at 4°C and 13,500 g for 10 min, and the resulting supernatant (MeOH/ water (MW) extracts) was transferred to a 2 mL microcentrifuge tube. The remaining pellets were extracted again with 1 mL of the mixture solvent (dichloromethane:MeOH, 3∶1, v/v). The supernatants (dichloromethane/MeOH (DM) extracts) were collected in new microcentrifuge tubes following centrifugation. Each extract solution was evaporated with a speed-vacuum machine. Dried samples were stored at −80°C.To each "MW" sample, 300 μL of ACN was added. To each "DM" sample, 100 μL of ACN was added. Samples were vortexed vigorously, then centrifuged at 15000 rpm for 15 min. 25 μL of supernatant was taken from each sample for LCMS analysis.
Two μL of sample or standard solution was injected into Sciex Qtrap 6500 coupled with Agilent 1290 UPLC system. All samples were eluted by Phenomenex Kinetex C18 column (1.7 μm, 2.1 × 50 mm) kept at 40 degrees at a flow rate of 450 ul/min. LC elution started with 60% mobile phase A (5% ACN in H2O with 0.1% FA) for 1 min, followed by a linear gradient increase of mobile phase B (ACN with 0.1% FA) from 40 to 95% in 2 min. MS data were acquired by MRM scan at positive mode. The ESI spray voltage and source temperature was set at 4.7 kV and 450 degrees. Positively charged rotenone was detected by monitoring its transitions to signature product ions 395 > 192 and 395 > 213. The quantification was achieved using the peak area of monitored transition 395 > 213.
The standard curve of rotenone was plotted with the concentration as X axis and the peak area of the target as Y axis. Six non-zero calibrators were used to construct the standard curve. The curve was fitted by linear regression with a weighting factor of 1/x. The norminal concentrations, back calculated concentrations and accraucy of calibrators are listed in Table 1 . The accuracy of each calibrator is within the acceptable range of 15%. The limit of quantitation (LOQ) is 0.1 ng/ mL-with 2 μL injection that results in 200 fg on column. Lower point 0.05 ng/mL (100 fg on column) was detectable but not quantifiable. Good concentration-response linearty (r = 0.9999) was established over the range from 0.1 ng/mL to 100 ng/mL. Quantitation results were generated using Analyst software.
Statistical analyses
All data are reported as mean + standard error of the mean (SEM), unless otherwise stated. Differences among means were analyzed using GraphPad Prism (v5.03) software (GraphPad Software, Chicago, IL). Repeated measures (rm) analysis of variance (ANOVA) was performed to evaluate the time effect on various behavior parameters among groups. Two-tailed unpaired independent t-test was performed to compare two groups. One-way ANOVA was performed to evaluate the significance differences between multiple groups. Two-way ANOVA was performed to evaluate the significant differences with conditions (control vs RS), treatments (vehicle vs rotenone) or an interaction (stress by rotenone). Multiple group comparisons were performed using Bonferroni post-hoc comparisons. The significance was considered at the value P < .05.
Supplementary data to this article can be found online at https:// doi.org/10.1016/j.nbd.2018.12.012.
